Literature DB >> 3489661

An immunohistochemical study of non-Hodgkin's lymphomas: correlation of morphological appearances and immunophenotype in 148 cases.

J R Nash.   

Abstract

An unselected series of 148 cases of non-Hodgkin's lymphoma has been studied by immunohistological methods. In each case, the morphological features displayed in paraffin sections were correlated with the immunophenotype, determined using a panel of monoclonal antibodies. Of the lymphomas 82% were B-cell type, 28% of follicle centre cell origin, 17% lymphocytic or immunocytic and 30% of large cell type. All the B-cell tumours expressed pan-B antigen, and nearly all HLA-DR. In most, light chain monoclonality was demonstrable. Nearly all had moderate to large numbers of T-cells of both subtypes interspersed amongst the B-lymphocytes. Follicle centre cell tumours expressed surface IgM and IgD and had numerous dendritic reticulum cells. Lymphocytic and immunocytic lymphoma expressed IgM but less IgD, and had fewer or no dendritic reticulum cells. Large cell lymphoma expressed either no immunoglobulin or only IgM, and contained ragged dendritic reticulum cells, giving the appearance of 'burnt-out' follicles. T-cell lymphomas usually showed a clear preponderance of either helper or suppressor subtype. Additionally, they contained residual B-cells and sometimes germinal centres. Only 3% of this series were 'non-B, non-T', and only one case HLA-DR negative, so the 'null' or 'unclassifiable' group is very small when information from antibody markers is available.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489661     DOI: 10.1111/j.1365-2559.1986.tb02579.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  2 in total

1.  Dendritic reticulum cell-related immunostaining for laminin in follicular and diffuse B-cell lymphomas.

Authors:  A Gloghini; A Carbone
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma.

Authors:  J A Green; R D Errington; J R Nash; M A Coe; H M Warenius
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.